Jani Saarela

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

NPJ precision oncology

Oncogenesis

NPJ biofilms and microbiomes

Nature protocols

University of Helsinki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki Sep 01 2010

Finland

senior researcher :: High Throughput Biomedicine unit

National Institute for Health and Welfare Jul 01 2007 - Aug 31 2010

Finland

post-doctoral researcher

Medical University of Vienna Apr 01 2004 - Jun 30 2007

Austria

post-doctoral researcher

National Public Health Institute May 20 1996 - Mar 31 2004

Finland

undergraduate and PhD student

Publications

Mehdi Mirzaie, Elham Gholizadeh, Juho J Miettinen, Filipp Ianevski, Tanja Ruokoranta, Jani Saarela, Mikko Manninen, Susanna Miettinen, Caroline A Heckman, Mohieddin Jafari
Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling. Oncogenesis 13 (1) (2024)
Mehdi Mirzaie, Elham Gholizadeh, Juho J Miettinen, Filipp Ianevski, Tanja Ruokoranta, Jani Saarela, Mikko Manninen, Susanna Miettinen, Caroline A Heckman, Mohieddin Jafari
Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling. Oncogenesis 13 (1) (2024)
Swapnil Potdar, Filipp Ianevski, Aleksandr Ianevski, Ziaurrehman Tanoli, Krister Wennerberg, Brinton Seashore-Ludlow, Olli Kallioniemi, Päivi Östling, Tero Aittokallio, Jani Saarela
Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data. Nucleic acids research (2023)
Yingjia Chen, Liye He, Aleksandr Ianevski, Pilar Ayuda-Durán, Swapnil Potdar, Jani Saarela, Juho J Miettinen, Sari Kytölä, Susanna Miettinen, Mikko Manninen, Caroline A Heckman, Jorrit M Enserink, Krister Wennerberg, Tero Aittokallio
Robust scoring of selective drug responses for patient-tailored therapy selection. Nature protocols (2023)
Veera Kainulainen, Carina von Schantz-Fant, Ruusu-Maria Kovanen, Swapnil Potdar, Karoliina Laamanen, Jani Saarela, Satokari Reetta
Genome-wide siRNA screening reveals several host receptors for the binding of human gut commensal Bifidobacterium bifidum. NPJ biofilms and microbiomes 8 (1) (2022)
Heike Peterziel, Nora Jamaladdin, Dina ElHarouni, Xenia F Gerloff, Sonja Herter, Petra Fiesel, Yannick Berker, Mirjam Blattner-Johnson, Kathrin Schramm, Barbara C Jones, David Reuss, Laura Turunen, Aileen Friedenauer, Tim Holland-Letz, Martin Sill, Lena Weiser, Christopher Previti, Gnanaprakash Balasubramanian, Nicolas U Gerber, Johannes Gojo, Caroline Hutter, Ingrid Öra, Olli Lohi, Antonis Kattamis, Bram de Wilde, Frank Westermann, Stephan Tippelt, Norbert Graf, Michaela Nathrath, Monika Sparber-Sauer, Astrid Sehested, Christof Maria Kramm, Uta Dirksen, Olli Kallioniemi, Stefan M Pfister, Cornelis M van Tilburg, David T W Jones, Jani Saarela, Vilja Pietiäinen, Natalie Jäger, Matthias Schlesner, Dominik T Schneider, Sina Oppermann, Till Milde, Olaf Witt, Ina Oehme
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. NPJ precision oncology 6 (1) (2022)
Heike Peterziel, Nora Jamaladdin, Dina ElHarouni, Xenia F Gerloff, Sonja Herter, Petra Fiesel, Yannick Berker, Mirjam Blattner-Johnson, Kathrin Schramm, Barbara C Jones, David Reuss, Laura Turunen, Aileen Friedenauer, Tim Holland-Letz, Martin Sill, Lena Weiser, Christopher Previti, Gnanaprakash Balasubramanian, Nicolas U Gerber, Johannes Gojo, Caroline Hutter, Ingrid Öra, Olli Lohi, Antonis Kattamis, Bram de Wilde, Frank Westermann, Stephan Tippelt, Norbert Graf, Michaela Nathrath, Monika Sparber-Sauer, Astrid Sehested, Christof Maria Kramm, Uta Dirksen, Olli Kallioniemi, Stefan M Pfister, Cornelis M van Tilburg, David T W Jones, Jani Saarela, Vilja Pietiäinen, Natalie Jäger, Matthias Schlesner, Dominik T Schneider, Sina Oppermann, Till Milde, Olaf Witt, Ina Oehme
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. NPJ precision oncology 6 (1) (2022)
Heike Peterziel, Nora Jamaladdin, Dina ElHarouni, Xenia F Gerloff, Sonja Herter, Petra Fiesel, Yannick Berker, Mirjam Blattner-Johnson, Kathrin Schramm, Barbara C Jones, David Reuss, Laura Turunen, Aileen Friedenauer, Tim Holland-Letz, Martin Sill, Lena Weiser, Christopher Previti, Gnanaprakash Balasubramanian, Nicolas U Gerber, Johannes Gojo, Caroline Hutter, Ingrid Öra, Olli Lohi, Antonis Kattamis, Bram de Wilde, Frank Westermann, Stephan Tippelt, Norbert Graf, Michaela Nathrath, Monika Sparber-Sauer, Astrid Sehested, Christof Maria Kramm, Uta Dirksen, Olli Kallioniemi, Stefan M Pfister, Cornelis M van Tilburg, David T W Jones, Jani Saarela, Vilja Pietiäinen, Natalie Jäger, Matthias Schlesner, Dominik T Schneider, Sina Oppermann, Till Milde, Olaf Witt, Ina Oehme
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. NPJ precision oncology 6 (1) (2022)
Maral Jamshidi, Rainer Fagerholm, Taru A Muranen, Sippy Kaur, Swapnil Potdar, Sofia Khan, Eliisa Netti, John-Patrick Mpindi, Bhagwan Yadav, Johanna I Kiiski, Kristiina Aittomäki, Päivi Heikkilä, Jani Saarela, Ralf Bützow, Carl Blomqvist, Heli Nevanlinna
High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome. Cancers 13 (12) (2021)
Disha Malani, Ashwini Kumar, Oscar Bruck, Mika Kontro, Bhagwan Yadav, Monica Hellesøy, Heikki Kuusanmaki, Olli Dufva, Matti Kankainen, Samuli Eldfors, Swapnil Potdar, Jani Saarela, Laura Turunen, Alun Parsons, Imre Vastrik, Katja Kivinen, Janna Saarela, Riikka Raty, Minna Lehto, Maija Wolf, Bjorn Tore Gjertsen, Mohamed El Missiry, Tero Aittokallio, Krister Wennerberg, Caroline A Heckman, Olli Kallioniemi, Kimmo Porkka
Implementing a functional precision medicine tumor board for acute myeloid leukemia. Cancer discovery (2021)
Karin Hansson, Katarzyna Radke, Kristina Aaltonen, Jani Saarela, Adriana Mañas, Jonas Sjölund, Emma M Smith, Kristian Pietras, Sven Påhlman, Krister Wennerberg, David Gisselsson, Daniel Bexell
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. Science translational medicine 12 (562) (2021)
Laura Torrente, Gunjit Maan, Asma Oumkaltoum Rezig, Jean A Quinn, Angus Jackson, Andrea Grilli, Laura Casares, Ying Zhang, Evgeny Kulesskiy, Jani Saarela, Silvio Bicciato, Joanne Edwards, Albena T Dinkova-Kostova, Laureano de la Vega
High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro. Biomolecules 10 (10) (2020)
Linping Wang, Jani Saarela, Sylvain Poque, Jari P T Valkonen
Development of FRET-based high-throughput screening for viral RNase III inhibitors. Molecular plant pathology 21 (7) (2020)
Jarle Bruun, Kushtrim Kryeziu, Peter W Eide, Seyed H Moosavi, Ina A Eilertsen, Jonas Langerud, Bård Røsok, Max Z Totland, Tuva H Brunsell, Teijo Pellinen, Jani Saarela, Christian H Bergsland, Hector G Palmer, Kristoffer W Brudvik, Tormod Kyrre Guren, Rodrigo Dienstmann, Marianne Grønlie Guren, Arild Nesbakken, Bjørn Atle Bjørnbeth, Anita Sveen, Ragnhild A Lothe
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)

Jani Saarela.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jani Saarela